Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features

Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01222715	Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma	completed	Phase 2	87	National Cancer Institute (NCI)NIH	4	May 5, 2017	clinicaltrials
NCT00720174	Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma	completed	Phase 1	30	National Cancer Institute (NCI)NIH	1	May 17, 2016